Sarepta Therapeutics | SRPT - القيمة السوقية





القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.53B 57M 2026-04
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 27.49B 589M 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Daiichi Sankyo JPY 4.9T 1.44T 2026-04
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Incyte USD 21.96B 3.23B 2026-04
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12